Berlin Industries has been acquired by KOBAYASHI Pharmaceutical Co.Ltd.
Dubilier & Company has sold Berlin Industries to KOBAYASHI Pharmaceutical Co., Ltd. for an undisclosed consideration.
Berlin Industries is a leading innovator and provider of naturally based, effective over-the-counter topical analgesic solutions sold under the Zim’s MAX™ brand. The company offers a complete line of naturally based topical analgesics including gel, roll-on, spray and recently introduced patches. Zim’s MAX Freeze provides temporary relief for minor aches and pains of muscle and joints associated with soreness, arthritis, strains, bruises and sprains.
KOBAYASHI Pharmaceutical manufactures and sells consumer products in Japan and internationally. The company offers OTC pharmaceuticals, oral hygiene products, food products, nutritional supplements, sanitary products, household products, skincare products, body warmers, cooling gel sheets and other items. .
Dubilier & Company is a private investment firm focused on buying and building companies in partnership with management.
Oaklins' team in Los Angeles advised the seller in this transaction.
Talk to the deal team
Steven Davis
Oaklins Intrepid
Lauren Antion Hansen
Oaklins Intrepid
Related deals
Dolmans Landscaping Group has welcomed Foreman Capital as a new shareholder to support further growth
Dolmans Landscaping Group, a leading full-service provider of landscaping services, has welcomed Foreman Capital as a new shareholder. By partnering with Foreman Capital, which has extensive experience in building stronger companies in the maintenance of public spaces, Dolmans can accelerate its growth trajectory across core verticals and further professionalize the business.
Learn moreBackspin has completed a mandatory public tender offer for the shares of Spindox
Backspin S.p.A. has completed a mandatory public tender offer for Spindox S.p.A.
Learn moreValmiermuižas Alus has been acquired by Cēsu Alus
Valmiermuižas Alus has been acquired by Cēsu Alus AS through the purchase of 100% of its shares. The transaction enabled the founder’s exit and strengthened the company’s platform for continued growth within a consolidating Baltic beverage market.
Learn more